Eberhardt publishes in Journal of Virology
TAA member Meghan Eberhardt was published as first author of a study entitled “Vaccination against a Virus-Encoded Cytokine Significantly Restricts Viral Challenge”, which appears in the November issue of the Journal of Virology. The study involves an experimental vaccine against the cytomegalovirus (CMV) infection which proved safe and more effective than previous vaccines for the virus. Eberhardt recently received her Doctorate of Comparative Pathology from the University of California, Davis. With a research emphasis on virology and immunology, Eberhardt has published 8 peer-reviewed publications, two first author and six contributing author.